Strota / LALPATHLAB / Quarterly results

Dr. Lal Path Labs Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Dr. Lal Path Labs' quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹798 crore (+19.1% year on year), net profit ₹170 crore (+28.0% year on year), EPS ₹10.15. Announced 24 Jul 2026, 5:58 pm IST. The shares rose 3.87% on 27 Jul 2026, 2.90 points better than the Nifty 50. Next results board meeting: 4 Nov 2026.
Revenue
₹798 cr
YoY +19.1% · QoQ +13.5%
Net profit
₹170 cr
YoY +28.0% · QoQ +29.1%
EPS (basic)
₹10.15
YoY -36.1%
Share price reaction
+3.9%
27 Jul 2026 · vs Nifty +2.9%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹603 cr Q4 FY25 net profit: ₹155 cr Q4 FY25 Q1 FY26 Revenue: ₹670 cr Q1 FY26 net profit: ₹132 cr Q1 FY26 Q2 FY26 Revenue: ₹731 cr Q2 FY26 net profit: ₹151 cr Q2 FY26 Q3 FY26 Revenue: ₹660 cr Q3 FY26 net profit: ₹90.50 cr Q3 FY26 Q4 FY26 Revenue: ₹703 cr Q4 FY26 net profit: ₹131 cr Q4 FY26 Q1 FY27 Revenue: ₹798 cr Q1 FY27 net profit: ₹170 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2724 Jul 2026, 5:58 pm IST 798+19.1%170+28.0% 21.2%10.15 +3.9%
Q4 FY2630 Apr 2026, 6:44 pm IST 703+16.6%131-15.2% 18.7%7.86 +15.1%
Q3 FY2630 Jan 2026, 5:49 pm IST 660—90.50— 13.7%5.42 +0.6%
Q2 FY2631 Oct 2025, 6:01 pm IST 731—151— 20.6%18.05 +3.8%
Q1 FY2631 Jul 2025, 3:49 pm IST 670—132— 19.8%15.88 +0.8%
Q4 FY2525 Apr 2025, 10:17 pm IST 603—155— 25.7%18.57 -3.4%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How LALPATHLAB shares react to results

Across the last 6 results here, the shares rose on 5 and fell on 1. The average move was +3.46%, and the average size of the move either way 4.60%; the biggest was +15.08% after the Q4 FY26 results. In the 1 quarters where profit grew year on year, the shares rose once.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Dr. Lal Path Labs' Q1 FY27 results?

For the quarter to 30 Jun 2026, Dr. Lal Path Labs reported revenue of ₹798 crore (+19.1% year on year) and net profit of ₹170 crore (+28.0%), with basic EPS of ₹10.15.

How did Dr. Lal Path Labs shares react to the Q1 results?

They rose 3.87% on 27 Jul 2026, the first session that could trade on the results (announced after the close); that was 2.90 points better than the Nifty 50 that day.

When is Dr. Lal Path Labs' next results date?

The board meets on 4 Nov 2026 to consider results, according to the company's intimation to NSE.

Do Dr. Lal Path Labs shares usually rise after results?

In the last 6 results here they rose 5 times and fell 1 times, moving 4.60% on average either way.

About this data

From Dr. Lal Path Labs' Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See LALPATHLAB stock page for price, open interest and deals, all results declared this week and the results calendar, and LALPATHLAB dividend history.